GZMB and urinary bladder carcinoma: However, prolonged systemic use of glucocorticoids has been shown to increase the subsequent risk of bladder cancer, possibly due to immunosuppression [71] or long-term induction of GRβ causing glucocorticoid resistance leading to inflammation.